Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2025-12-24 @ 10:15 PM
NCT ID:
NCT01602835
Eligibility Criteria:
Inclusion criteria:
* Alport syndrome diagnosis (clinical and/or histopathologic and/or genetic diagnosis, per subject's physician and/or genotyping)
* Physically able to provide a single first-morning urine sample of at least 30 mL
Exclusion criteria:
* Diagnosis of chronic kidney disease
* Receiving chronic phosphate-lowering therapy or erythropoietin therapy
* Ongoing chronic hemodialysis therapy and/or renal transplant recipient
* Nephrotic-range proteinuria: spot urine protein-to-creatinine ratio ≥ 3 on at least 2 of the last 3 clinical assessments Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Study:
NCT01602835
Study Brief:
Protocol Section:
NCT01602835